Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395213 · ClinicalTrials.gov registry record
Antidepressant Safety in Kids Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 569
- Enrollment target
NCT00395213 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 569 participants.
The verdict
NCT00395213 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 569 participants
- Enrollment target
Study Summary
This study will evaluate the risks and benefits of treatment with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor in children and adolescents with a pre-specified anxiety disorder, depressive disorder, eating disorder, or obsessive-compulsive disorder.
Interventions
- DRUG Selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 569 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00395213
The ClinicalTrials.gov registry entry for NCT00395213 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 569 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medications is the first listed.
NCT00395213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00395213 about?
NCT00395213 is a clinical study titled "Antidepressant Safety in Kids Study". This study will evaluate the risks and benefits of treatment with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor in children and adolescents with a pre-specified anxiety disorder, depressive disorder, eating disorder, or obsessive-compulsive disorder.
What is the current status of trial NCT00395213?
This trial is currently completed. The enrollment target is 569 participants. The study started on 2007-05. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00395213?
The interventions under investigation include: Selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medications (DRUG).
Who is sponsoring clinical trial NCT00395213?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.